In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 10th, 2004 | 28 | No |
Popular Name: MDL-2170 MDL-2170
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.17 | 8.75 | -13.21 | 2 | 6 | 0 | 85 | 382.46 | 10 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CAN1-1-E | Calpain 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 20 | 0.38 | Binding ≤ 10μM |
CAN2-1-E | Calpain 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
CANX-1-E | Calpain 1/2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
CATB-1-E | Cathepsin B (cluster #1 Of 6), Eukaryotic | Eukaryotes | 25 | 0.38 | Binding ≤ 10μM |
CATL1-1-E | Cathepsin L (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1270 | 0.29 | Binding ≤ 10μM |
CPNS1-1-E | Calpain Small Subunit 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 40 | 0.37 | Binding ≤ 10μM |
Q3HTL5-1-E | Falcipain 2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.27 | Binding ≤ 10μM |
Q9N6S8-1-E | Falcipain 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5000 | 0.27 | Binding ≤ 10μM |
CAN1-1-E | Calpain 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 700 | 0.31 | Functional ≤ 10μM |
CAN2-1-E | Calpain 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 700 | 0.31 | Functional ≤ 10μM |
CPNS1-1-E | Calpain Small Subunit 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 700 | 0.31 | Functional ≤ 10μM |
Z100494-1-O | C2C12 (Myoblast Cells) (cluster #1 Of 1), Other | Other | 10000 | 0.25 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 3981 | 0.27 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CAN1_HUMAN | P07384 | Calpain 1, Human | 10 | 0.40 | Binding ≤ 1μM |
CAN1_PIG | P35750 | Calpain 1, Pig | 10 | 0.40 | Binding ≤ 1μM |
CANX_CHICK | P00789 | Calpain 1/2, Chick | 10 | 0.40 | Binding ≤ 1μM |
CAN2_CHICK | Q92178 | Calpain 2, Chick | 10 | 0.40 | Binding ≤ 1μM |
CAN2_HUMAN | P17655 | Calpain 2, Human | 350 | 0.32 | Binding ≤ 1μM |
CPNS1_HUMAN | P04632 | Calpain Small Subunit 1, Human | 40 | 0.37 | Binding ≤ 1μM |
CPNS1_PIG | P04574 | Calpain Small Subunit 1, Pig | 20 | 0.38 | Binding ≤ 1μM |
CATB_HUMAN | P07858 | Cathepsin B, Human | 100 | 0.35 | Binding ≤ 1μM |
Z100494 | Z100494 | C2C12 (Myoblast Cells) | 10000 | 0.25 | Binding ≤ 10μM |
CAN1_HUMAN | P07384 | Calpain 1, Human | 10 | 0.40 | Binding ≤ 10μM |
CAN1_MOUSE | O35350 | Calpain 1, Mouse | 10000 | 0.25 | Binding ≤ 10μM |
CAN1_PIG | P35750 | Calpain 1, Pig | 10 | 0.40 | Binding ≤ 10μM |
CANX_CHICK | P00789 | Calpain 1/2, Chick | 10 | 0.40 | Binding ≤ 10μM |
CAN2_HUMAN | P17655 | Calpain 2, Human | 350 | 0.32 | Binding ≤ 10μM |
CAN2_CHICK | Q92178 | Calpain 2, Chick | 10 | 0.40 | Binding ≤ 10μM |
CPNS1_HUMAN | P04632 | Calpain Small Subunit 1, Human | 40 | 0.37 | Binding ≤ 10μM |
CPNS1_PIG | P04574 | Calpain Small Subunit 1, Pig | 20 | 0.38 | Binding ≤ 10μM |
CPNS1_MOUSE | O88456 | Calpain Small Subunit 1, Mouse | 10000 | 0.25 | Binding ≤ 10μM |
CATB_HUMAN | P07858 | Cathepsin B, Human | 100 | 0.35 | Binding ≤ 10μM |
CATL1_HUMAN | P07711 | Cathepsin L, Human | 1270 | 0.29 | Binding ≤ 10μM |
Q9N6S8_PLAFA | Q9N6S8 | Falcipain 2, Plafa | 5000 | 0.27 | Binding ≤ 10μM |
Q3HTL5_PLAFA | Q3HTL5 | Falcipain 2B, Plafa | 5000 | 0.27 | Binding ≤ 10μM |
CAN1_HUMAN | P07384 | Calpain 1, Human | 700 | 0.31 | Functional ≤ 10μM |
CAN2_HUMAN | P17655 | Calpain 2, Human | 700 | 0.31 | Functional ≤ 10μM |
CPNS1_HUMAN | P04632 | Calpain Small Subunit 1, Human | 700 | 0.31 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 3162.27766 | 0.28 | Functional ≤ 10μM |
Description | Species |
---|---|
Assembly of collagen fibrils and other multimeric structures | |
Collagen degradation | |
Degradation of the extracellular matrix | |
Endosomal/Vacuolar pathway | |
MHC class II antigen presentation | |
Trafficking and processing of endosomal TLR |